Trevi Therapeutics, Inc.

Trevi Therapeutics, Inc. - PE Ratioverified

TRVI

Price:

$17.21

Market Cap:

$2.44B

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the advancement and commercialization of Haduvio, a potential treatment for debilitating neurologically mediated conditions. This orally administered, extended-release formulation of nalbuphine is currently undergoing Phase IIb/III clinical trials for chronic pruritus (severe itching) and persistent cough experienced by patients with idiopathic pulmonary fibrosis. Trevi Therapeutics also possesses a licensing agreement with Endo Pharmaceuticals Inc., granting it the rights to develop and market products containing nalbuphine hydrochloride in various formulations. Established in 2011, the company maintains its c...[Read more]

Industry

Biotechnology

IPO Date

2019-05-07

Stock Exchange

NASDAQ

Ticker

TRVI

The PE Ratio as of June 2026 (TTM) for Trevi Therapeutics, Inc. (TRVI) is -53.78

According to Trevi Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -53.78. This represents a change of 64.57% compared to the average of -32.68 of the last 4 quarters.

Trevi Therapeutics, Inc. (TRVI) Historical PE Ratio (quarterly & annually)

How has TRVI PE Ratio performed in the past?

The mean historical PE Ratio of Trevi Therapeutics, Inc. over the last ten years is -8.57. The current -53.78 PE Ratio has changed 62.67% with respect to the historical average. Over the past ten years (40 quarters), TRVI's PE Ratio was at its highest in in the December 2021 quarter at -0.50. The PE Ratio was at its lowest in in the December 2025 quarter at -54.72.

Quarterly (TTM)
Annual

Average

-8.57

Median

-4.45

Minimum

-43.17

Maximum

-0.52

Trevi Therapeutics, Inc. (TRVI) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Trevi Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 716.98%

Maximum Annual PE Ratio = -0.52

Minimum Annual Increase = -60.74%

Minimum Annual PE Ratio = -43.17

Quarterly (TTM)
Annual
YearPE RatioChange
2025-43.17392.50%
2024-8.7789.71%
2023-4.627.74%
2022-4.29716.98%
2021-0.52-60.74%
2020-1.34-47.95%
2019-2.57-25.45%
2018-3.45-37.55%
2017-5.52-51.75%

Trevi Therapeutics, Inc. (TRVI) Average PE Ratio

How has TRVI PE Ratio performed in the past?

The current PE Ratio of Trevi Therapeutics, Inc. (TRVI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

-18.85

5-year avg

-12.27

10-year avg

-8.57

Trevi Therapeutics, Inc. (TRVI) PE Ratio vs. Peers

How is TRVI’s PE Ratio compared to its peers?

Trevi Therapeutics, Inc.’s PE Ratio is less than Ardelyx, Inc. (-25.72), less than Wave Life Sciences Ltd. (-5.81), less than Novavax, Inc. (-16.91), less than Zenas BioPharma, Inc. (-2.17), less than Upstream Bio, Inc. (-2.15), less than Tourmaline Bio, Inc. (-18.09), less than Terns Pharmaceuticals, Inc. (-51.41), less than Zymeworks Inc. (-16.90), less than Precigen, Inc. (-3.76), less than ORIC Pharmaceuticals, Inc. (-5.90),

Build a custom stock screener for Trevi Therapeutics, Inc. (TRVI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Trevi Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Trevi Therapeutics, Inc. (TRVI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Trevi Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Trevi Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Trevi Therapeutics, Inc. (TRVI)?

What is the highest PE Ratio for Trevi Therapeutics, Inc. (TRVI)?

What is the 3-year average PE Ratio for Trevi Therapeutics, Inc. (TRVI)?

What is the 5-year average PE Ratio for Trevi Therapeutics, Inc. (TRVI)?

How does the current PE Ratio for Trevi Therapeutics, Inc. (TRVI) compare to its historical average?